Bridger Gary 4
4 · X4 Pharmaceuticals, Inc · Filed Mar 14, 2019
Insider Transaction Report
Form 4
Bridger Gary
Director
Transactions
- Award
Stock Option (right to buy)
2019-03-13+21,570→ 21,570 totalExercise: $10.44Exp: 2028-10-03→ Common Stock (21,570 underlying)
Footnotes (2)
- [F1]Twenty-five percent (25%) of the shares subject to the option vested on October 4, 2019, and one thirty-sixth (1/36th) of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F2]Reflects the Reporting Person's stock option to acquire 226,983 shares of X4 common stock for $0.99 per share that was assumed by the Issuer in the merger of Artemis AC Corp., a wholly-owned subsidiary of the Issuer, with and into X4 Therapeutics, Inc. (formerly X4 Pharmaceuticals, Inc.) ("X4") on March 13, 2019 (the "Merger").